HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eradicating Helicobacter pylori and symptoms of non-ulcer dyspepsia.

AbstractOBJECTIVE:
To examine the effect of eradication of Helicobacter pylori on symptoms of non-ulcer dyspepsia.
DESIGN:
Four week prospective study.
SETTING:
One hospital outpatient and endoscopy department.
PATIENTS:
90 adults with persistent symptoms typical of non-ulcer dyspepsia but no clinical or endoscopic evidence of other peptic, biliary, pancreatic, or malignant disease; all had histological and microbiological evidence of infection with H pylori. 83 patients completed the treatment regimen.
INTERVENTION:
Colloidal bismuth subcitrate 120 mg four times a day for four weeks (27 patients); metronidazole 400 mg and amoxycillin 500 mg each three times a day for one week (27); and bismuth subcitrate 120 mg four times a day for four weeks, metronidazole 400 mg three times a day for one week, plus amoxycillin 500 mg three times a day for the first week (29).
MAIN OUTCOME MEASURES:
Change in symptom scores determined with questionnaire; histological evidence of gastritis and microbiological evidence of presence of H pylori in biopsy specimens.
RESULTS:
Overall, H pylori was eradicated in 41 (49%) patients. Although gastritis scores improved significantly in only patients in whom H pylori had been eradicated (from 1.56 to 0.61, p less than 0.01 v from 1.83 to 1.07, p = 0.52) mean symptom scores after treatment were similar in patients in whom H pylori had or had not been eradicated (3.0 v 2.3, NS). Similarly the mean symptom score improved whether or not gastritis improved (2.8 v 3.1 respectively, p = 0.72). The observations were similar for treatment groups analysed individually.
CONCLUSION:
Antral infection with the organism does not seem to have an important aetiological role in non-ulcer dyspepsia short term.
AuthorsS Patchett, S Beattie, E Leen, C Keane, C O'Morain
JournalBMJ (Clinical research ed.) (BMJ) Vol. 303 Issue 6812 Pg. 1238-40 (Nov 16 1991) ISSN: 0959-8138 [Print] England
PMID1747644 (Publication Type: Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article)
Chemical References
  • Organometallic Compounds
  • Metronidazole
  • Amoxicillin
  • bismuth tripotassium dicitrate
  • Bismuth
Topics
  • Adult
  • Aged
  • Amoxicillin (administration & dosage, therapeutic use)
  • Bismuth (administration & dosage, therapeutic use)
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Dyspepsia (complications, drug therapy)
  • Female
  • Helicobacter Infections (complications, drug therapy)
  • Helicobacter pylori
  • Humans
  • Male
  • Metronidazole (administration & dosage, therapeutic use)
  • Middle Aged
  • Organometallic Compounds (administration & dosage, therapeutic use)
  • Prospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: